Thrive Capital Management, LLC Abb Vie Inc. Transaction History

Thrive Capital Management, LLC

$211 Million
Q3 2024

A detailed history of Thrive Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Thrive Capital Management, LLC holds 1,669 shares of ABBV stock, worth $293,043. This represents 0.16% of its overall portfolio holdings.

Number of Shares

1,669

Previous 12,750 86.91%

Holding current value

$293,043

Previous $2.19 Million 84.95%

% of portfolio

0.16%

Previous 1.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $1.82 Million - $2.21 Million	-11,081 Reduced 86.91%	1,669 $329,000
Q2 2024 Aug 09, 2024	BUY	$154.79 - $180.76 $787,107 - $919,164	5,085 Added 66.34%	12,750 $2.19 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $732,455 - $834,564	4,583 Added 148.7%	7,665 $1.4 Million
Q4 2023 Jan 29, 2024	SELL	$137.6 - $154.97 $13,347 - $15,032	-97 Reduced 3.05%	3,082 $477,000
Q3 2023 Nov 02, 2023	SELL	$133.59 - $154.65 $801 - $927	-6 Reduced 0.19%	3,179 $473,000
Q2 2023 Aug 02, 2023	SELL	$132.51 - $164.9 $38,692 - $48,150	-292 Reduced 8.4%	3,185 $429,000
Q1 2023 May 08, 2023	BUY	$144.61 - $166.54 $20,968 - $24,148	145 Added 4.35%	3,477 $554,000
Q4 2022 Jan 18, 2023	BUY	$138.31 - $165.87 $13,692 - $16,421	99 Added 3.06%	3,332 $0
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $94,752 - $108,674	706 Added 27.94%	3,233 $434,000
Q2 2022 Aug 08, 2022	BUY	$137.62 - $174.96 $50,644 - $64,385	368 Added 17.04%	2,527 $387,000
Q1 2022 May 06, 2022	SELL	$131.98 - $163.75 $690,519 - $856,740	-5,232 Reduced 70.79%	2,159 $350,000
Q4 2021 Feb 09, 2022	SELL	$107.43 - $135.93 $837,309 - $1.06 Million	-7,794 Reduced 51.33%	7,391 $1 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $75,756 - $85,995	712 Added 4.92%	15,185 $1.64 Million
Q2 2021 Aug 06, 2021	BUY	$105.21 - $117.21 $538,780 - $600,232	5,121 Added 54.76%	14,473 $1.63 Million
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $272,629 - $300,132	2,665 Added 39.85%	9,352 $1.01 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $538,236 - $726,676	6,687 New	6,687 $716,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrive Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thrive Capital Management, LLC with notifications on news.

Account

Thrive Capital Management, LLC Abb Vie Inc. Transaction History